 |
A new study funded in part by the US National MS Society shows for the first time that blocking a segment of fibrinogen – a protein essential for blood clotting – reduces inflammation and symptoms in mice with an MS-like disease, apparently without interfering with normal blood clotting.
To read more, please click on the link below.
Source: US National MS Society
Weblink: click here
|
